Mereo BioPharma receives extension from Nasdaq to regain minimum bid price compliance
Mereo BioPharma Group plc (NASDAQ:MREO) announced it has received a second 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement. The company now has until February 16, 2027, to ensure its American Depositary Shares trade at or above $1.00 for …